These benefits, together with a former report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 assistance the concept of targeting ACKR3 as a unique solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-connected disorders.(two) The doctor has received a publish